Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Claudio Marroni"'
Autor:
Santiago Rodrıguez, Alfeu de Medeiros Fleck, Jr., Marcos Mucenic, Claudio Marroni, Ajacio Brandão
Publikováno v:
Annals of Hepatology, Vol 24, Iss , Pp 100500- (2021)
Background: In Brazil, the Model for End-Stage Liver Disease (MELD) score is used to prioritize patients for deceased donor liver transplantation (DDLT). Patients with hepatocellular carcinoma (HCC) receive standardized MELD exception points to accou
Externí odkaz:
https://doaj.org/article/3eaf56dde12b4dc6a7f9522f79df98d4
Autor:
Norberto C. Chávez-Tapia, Ezequiel Ridruejo, Angelo Alves de Mattos, Fernando Bessone, Jorge Daruich, Juan F. Sánchez-Ávila, Hugo Cheinquer, Rodrigo Zapata, Misael Uribe, Francisco Bosques-Padilla, Adrián Gadano, Alejandro Soza, Milagros Dávalos-Moscol, Claudio Marroni, Linda Muñoz-Espinoza, Graciela Castro-Narro, Raymundo Paraná, Nahum Méndez-Sánchez, MD, MSc, PhD, FACG, AGAF
Publikováno v:
Annals of Hepatology, Vol 12, Iss , Pp S3-S35 (2013)
Hepatitis C is a common cause of end-stage liver disease, and the main indication for liver transplantation in Latin America. Treatment of hepatitis C infected patients improves important long-term outcomes as mortality. Sustained viral response is r
Externí odkaz:
https://doaj.org/article/62e1b482d3044194b064e69f531bece9
Autor:
Adriana, Machado, Guillermo, Kiss, Lucas, Ernani, Claudio, Marroni, Maria Lúcia, Zanotelli, Guido, Cantisani, Carlos Thadeu, Cerski, Gabriela, Coral, Ajacio, Brandão, Mário Henrique, Meine
Publikováno v:
Clinical transplantation. 29(9)
This retrospective study evaluated the ability of the Metroticket model to predict five-yr post-transplant survival in patients with hepatocellular carcinoma (HCC) based only on explant data. Five-yr survival after transplant was estimated using the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9d2a7c851da29a0c29da3ea2e2b53d0
https://pubmed.ncbi.nlm.nih.gov/26119109
https://pubmed.ncbi.nlm.nih.gov/26119109
Autor:
Caroline Possa, Marroni, Ajácio Bandeira, de Mello Brandão, Alexandre Wahl, Hennigen, Claudio, Marroni, Maria Lúcia, Zanotelli, Guido, Cantisani, Sandra Costa, Fuchs, Mário Henrique, de Mattos Meine
Publikováno v:
Clinical transplantation. 26(4)
To compare the accuracy of standard model for end-stage liver disease (MELD) score with that of four MELD-based scores incorporating serum sodium (SNa) to predict three- and six-month mortality in cirrhotic patients after their placement on the waiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d125a3b90082891956de2c31caddac2e
https://pubmed.ncbi.nlm.nih.gov/22882694
https://pubmed.ncbi.nlm.nih.gov/22882694
Autor:
Ajacio, Brandão, Sandra C, Fuchs, Ana L, Gleisner, Claudio, Marroni, Maria L, Zanotelli, Guido, Cantisani
Publikováno v:
Clinical transplantation. 22(5)
To examine the performance of the model for end-stage liver disease (MELD) score to predict mortality three and six months after enlistment of patients with chronic diseases for their first liver transplantation (LT) and to compare the performances o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07164d58a46ce5e182a142b941829f23
https://pubmed.ncbi.nlm.nih.gov/18549449
https://pubmed.ncbi.nlm.nih.gov/18549449
Autor:
Claudio Marroni, Luis Grande, Miquel Navasa, Joan Rodés, Hernan Andreu, Antoni Rimola, Juan Carlos García-Valdecasas, Javier Bustamante, Eleazar González, Enric Esmatjes, Isabel Cirera
Publikováno v:
Journal of hepatology. 25(1)
To investigate the prevalence and risk factors for the development of diabetes mellitus after orthotopic liver transplantation, we reviewed 27 variables (including previous history of diabetes mellitus, data related to pre-transplant liver disease, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1566a488c1137aa7a551171c3955d37
https://pubmed.ncbi.nlm.nih.gov/8836903
https://pubmed.ncbi.nlm.nih.gov/8836903
Autor:
Mariana de Andrade Pranke, Maria Lúcia Zanotelli, Alfeu Fleck Jr., Ajácio Brandão, Cláudio Marroni, Guido Cantisani
Publikováno v:
Brazilian Journal of Transplantation, Vol 20, Iss 2 (2017)
The introduction of the everolimus as immunosuppressant in the liver transplantation has been shown to be safe and effective in the prophylaxis and preservation of the renal function. Prospective follow-up and chart analysis of liver transplant patie
Externí odkaz:
https://doaj.org/article/90c9c0d54576421893f3cd69934f07dc
Autor:
Ane M. Costabeber, Lívia C. Lionço, Cláudio Marroni, Maria L. Zanotelli, Guido Cantisani, Ajácio Brandão, M.D., Ph.D.
Publikováno v:
Annals of Hepatology, Vol 13, Iss 6, Pp 781-787 (2014)
Background. The D-MELD score was designed to prevent donor-recipient matches with a high risk of unfavorable outcome. The main objective of the present study was to assess the predictive value of the D-MELD score for 1-month and 3-month post-transpla
Externí odkaz:
https://doaj.org/article/4c206c887c654124a0cf0453bbb7d5f2
Autor:
Adriana Gonçalves da Silva Machado, Alfeu de Medeiros Fleck Jr., Cláudio Marroni, Maria Lúcia Zanotelli, Guido Cantisani, Ajácio Bandeira de Mello Brandão
Publikováno v:
Annals of Hepatology, Vol 12, Iss 3, Pp 440-447 (2013)
Introduction. Model for end-stage liver disease (MELD) is an accurate predictor of mortality in patients with cirrhosis, and has been used on liver allocation in Brazil since 2006. However, its impact on organ allocation, waiting list and post-transp
Externí odkaz:
https://doaj.org/article/83119fe4f45d4c5f931b714c2ffc2518
Autor:
Gustavo Pereira-Filho, Clarissa Ferreira, Alex Schwengber, Cláudio Marroni, Cláudio Zettler, Norma Marroni
Publikováno v:
Arquivos de Gastroenterologia, Vol 45, Iss 2, Pp 156-162 (2008)
BACKGROUND: Hepatic cirrhosis is the final stage of liver dysfunction, characterized by diffuse fibrosis which is the main response to the liver injury. The inhalatory carbon tetrachloride is an effective experimental model that triggers cirrhosis an
Externí odkaz:
https://doaj.org/article/5ec181bc20a943a3969f61bcc2d3fbb3